Related references
Note: Only part of the references are listed.Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
Sergio Linares-Fernandez et al.
TRENDS IN MOLECULAR MEDICINE (2020)
The challenge and prospect of mRNA therapeutics landscape
Yuhua Weng et al.
BIOTECHNOLOGY ADVANCES (2020)
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
Katharina Reinhard et al.
SCIENCE (2020)
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
Elinor Willis et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
Brenda De Keersmaecker et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Abishek Wadhwa et al.
PHARMACEUTICS (2020)
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
Cynthia Liu et al.
ACS CENTRAL SCIENCE (2020)
Fluorescence-Based Quantification of Messenger RNA and Plasmid DNA Decay Kinetics in Extracellular Biological Fluids and Cell Extracts
Heyang Zhang et al.
ADVANCED BIOSYSTEMS (2020)
Investigation of charge ratio variation in mRNA - DEAE-dextran polyplex delivery systems
C. Siewert et al.
BIOMATERIALS (2019)
Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation
Anne-Line Coolen et al.
BIOMATERIALS (2019)
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
Martin Sebastian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Safety and immunogenicity of a mRNA-based chikungunya vaccine in a phase 1 dose-ranging trial
C. Shaw et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Giulietta Maruggi et al.
MOLECULAR THERAPY (2019)
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski et al.
MOLECULAR THERAPY (2019)
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
Alvin J. Mukalel et al.
CANCER LETTERS (2019)
Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination
Xiaoyi Sun et al.
JOURNAL OF GENE MEDICINE (2019)
mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo
Yulia Rybakova et al.
MOLECULAR THERAPY (2019)
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Robert A Feldman et al.
VACCINE (2019)
A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
Markus Baiersdoerfer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Therapeutic mRNA delivery to leukocytes
Yasmin Granot-Matok et al.
JOURNAL OF CONTROLLED RELEASE (2019)
High Pressure Nebulization (PIPAC) Versus Injection for the Intraperitoneal Administration of mRNA Complexes
Molood Shariati et al.
PHARMACEUTICAL RESEARCH (2019)
A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
Nurgun Kose et al.
SCIENCE IMMUNOLOGY (2019)
Three decades of messenger RNA vaccine development
Rein Verbeke et al.
NANO TODAY (2019)
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
Lei Miao et al.
NATURE BIOTECHNOLOGY (2019)
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
Sita Awasthi et al.
SCIENCE IMMUNOLOGY (2019)
Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine
Zifu Zhong et al.
VACCINES (2019)
Advances in RNA Vaccines for Preventive Indications: A Case Study of a Vaccine against Rabies
Nicole Armbruster et al.
VACCINES (2019)
Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
Asha Kumari Patel et al.
ADVANCED MATERIALS (2019)
2754. Phase 1 Trial of an mRNA-Based Combination Vaccine Against hMPV and PIV3
Christine Shaw et al.
Open Forum Infectious Diseases (2019)
Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening
Alexandra G. Orlandini von Niessen et al.
MOLECULAR THERAPY (2019)
Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice
Marcelo M. Samsa et al.
MOLECULAR THERAPY (2019)
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix
Wesley de Jong et al.
VACCINES (2019)
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
Ludwig Heesen et al.
CANCER RESEARCH (2019)
Safety Evaluation of Lipid Nanoparticle-Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey
Maja Sedic et al.
VETERINARY PATHOLOGY (2018)
Fluorescence Correlation Spectroscopy to find the critical balance between extracellular association and intracellular dissociation of mRNA complexes
Heyang Zhang et al.
ACTA BIOMATERIALIA (2018)
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection
Cynthia L. Gay et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)
Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice
Sebastian Rosigkeit et al.
MOLECULAR PHARMACEUTICS (2018)
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Ema Robinson et al.
MOLECULAR THERAPY (2018)
Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency
Mary G. Prieve et al.
MOLECULAR THERAPY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles
Marianna Yanez Arteta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection
Alvaro Baeza Garcia et al.
NATURE COMMUNICATIONS (2018)
Poly(β-amino ester)-co-poly(caprolactone) Terpolymers as Nonviral Vectors for mRNA Delivery In Vitro and In Vivo
Umberto Capasso Palmiero et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin
Sonia Golombek et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification
Sriram Vaidyanathan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Combinatorial treatment with intratumoral cytokine mRNAs results in high frequency of tumor rejection and development of anti-tumor immunity across a range of preclinical cancer models
Timothy R. Wagenaar et al.
CANCER RESEARCH (2018)
A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
Robert A. Jabulowsky et al.
CANCER RESEARCH (2018)
Optimization of a Degradable Polymer-Lipid Nanoparticle for Potent Systemic Delivery of mRNA to the Lung Endothelium and Immune Cells
James C. Kaczmarek et al.
NANO LETTERS (2018)
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Norbert Pardi et al.
NATURE COMMUNICATIONS (2018)
Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch)
Kai Jun Koh et al.
SCIENTIFIC REPORTS (2018)
Cationic lipid-assisted nanoparticles for delivery of mRNA cancer vaccine
Ya-Nan Fan et al.
BIOMATERIALS SCIENCE (2018)
Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles
Hanzey Yasar et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection
Lorna Leal et al.
AIDS (2018)
Highly Efficient In Vivo Targeting of the Pulmonary Endothelium Using Novel Modifications of Polyethylenimine: An Importance of Charge
Andrew W. Dunn et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA
Canan Schumann et al.
THERANOSTICS (2018)
Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)
Alberto C. Guardo et al.
AIDS (2017)
Mechanism of action of mRNA-based vaccines
Carlo Iavarone et al.
EXPERT REVIEW OF VACCINES (2017)
Continuous microfluidic assembly of biodegradable poly(beta-amino ester)/DNA nanoparticles for enhanced gene delivery
David R. Wilson et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2017)
Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design
Timothy Pepini et al.
JOURNAL OF IMMUNOLOGY (2017)
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
Martin Alberer et al.
LANCET (2017)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl et al.
MOLECULAR THERAPY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
Short poly(A) tails are a conserved feature of highly expressed genes
Sarah Azoubel Lima et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Type I lnterferons Modulate CD8+ T Cell Immunity to mRNA Vaccines
Ans De Beuckelaer et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
Giulietta Maruggi et al.
VACCINE (2017)
Short poly(A) tails are a conserved feature of highly expressed genes
Sarah Azoubel Lima et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications
Tatjana Michel et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Tools for translation: non-viral materials for therapeutic mRNA delivery
Khalid A. Hajj et al.
NATURE REVIEWS MATERIALS (2017)
Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients With Acute Myeloid Leukemia
Hanna J. Khoury et al.
CANCER (2017)
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
Kristen A. Batich et al.
CLINICAL CANCER RESEARCH (2017)
Modified mRNA Vaccines Protect against Zika Virus Infection
Justin M. Richner et al.
CELL (2017)
Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA
Mengnan Zhao et al.
DRUG DELIVERY (2016)
Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
Michela Brazzoli et al.
JOURNAL OF VIROLOGY (2016)
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
Sandra Van Lint et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Polymer-Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs
James C. Kaczmarek et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice
Abderraouf Selmi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
Oezlem Tuereci et al.
CLINICAL CANCER RESEARCH (2016)
Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial
Rajesh T. Gandhi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
Sofie Wilgenhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Materials for non-viral intracellular delivery of messenger RNA therapeutics
Kevin J. Kauffman et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Regulation of Poly(A) Tail and Translation during the Somatic Cell Cycle
Jong-Eun Park et al.
MOLECULAR CELL (2016)
Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses
Ans De Beuckelaer et al.
MOLECULAR THERAPY (2016)
Variable Virulence and Efficacy of BCG Vaccine Strains in Mice and Correlation With Genome Polymorphisms
Lu Zhang et al.
MOLECULAR THERAPY (2016)
Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo
Yizhou Dong et al.
NANO LETTERS (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential
Malwina Strenkowska et al.
NUCLEIC ACIDS RESEARCH (2016)
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
Jasdave S. Chahal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
Aleksandra Kowalczyk et al.
VACCINE (2016)
Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours
Lukasz Bialkowski et al.
SCIENTIFIC REPORTS (2016)
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
Margit Schnee et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair
Patricia Peking et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences
Alexandra E Grier et al.
Molecular Therapy-Nucleic Acids (2016)
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Norbert Pardi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Stability analysis of chemically modified mRNA using micropattern-based single-cell arrays
Mehrije Ferizi et al.
LAB ON A CHIP (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Hubert Kuebler et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Electroporation-enhanced delivery of nucleic acid vaccines
Kate E. Broderick et al.
EXPERT REVIEW OF VACCINES (2015)
The ReNAissanCe of mRNA-based cancer therapy
Sandra Van Lint et al.
EXPERT REVIEW OF VACCINES (2015)
mRNA-based dendritic cell vaccines
Daphne Benteyn et al.
EXPERT REVIEW OF VACCINES (2015)
Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion
Willy M. Bogers et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy
Heleen Dewitte et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
Luis A. Brito et al.
MOLECULAR THERAPY (2014)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5′-terminal regions of cap0-, cap1-and 5′ppp- mRNAs
Parimal Kumar et al.
NUCLEIC ACIDS RESEARCH (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Modified Foxp3 mRNA protects against asthma through an IL-10 dependent mechanism
Lauren E. Mays et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format
Kyle K. L. Phua et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Michele D. Tameris et al.
LANCET (2013)
Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
Charlotte Pollard et al.
MOLECULAR THERAPY (2013)
mRNA Transfection of Mouse and Human Neural Stem Cell Cultures
Samuel McLenachan et al.
PLOS ONE (2013)
A novel, disruptive vaccination technology Self-adjuvanted RNActive® vaccines
Karl-Josef Kallen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Trial Watch Dendritic cell-based interventions for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2013)
Cationic lipids activate intracellular signaling pathways
Caroline Lonez et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety-fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis
Anna M. Rydzik et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
Sandra Van Lint et al.
CANCER RESEARCH (2012)
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Damian C. Ekiert et al.
NATURE (2012)
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
Benjamin Petsch et al.
NATURE BIOTECHNOLOGY (2012)
Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
Daniel X. Johansson et al.
PLOS ONE (2012)
Poly(β-Amino Ester)-Nanoparticle Mediated Transfection of Retinal Pigment Epithelial Cells In Vitro and In Vivo
Joel C. Sunshine et al.
PLOS ONE (2012)
Nonviral delivery of self-amplifying RNA vaccines
Andrew J. Geall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Developing mRNA-vaccine technologies
Thomas Schlake et al.
RNA BIOLOGY (2012)
Targeting the tumor mutanome for personalized vaccination therapy
Sebastian Kreiter et al.
ONCOIMMUNOLOGY (2012)
Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1
Irina Vlasova-St Louis et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
Mariola Fotin-Mleczek et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Michael S. D. Kormann et al.
NATURE BIOTECHNOLOGY (2011)
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
Katalin Kariko et al.
NUCLEIC ACIDS RESEARCH (2011)
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
Bart R. Anderson et al.
NUCLEIC ACIDS RESEARCH (2011)
Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
Sebastian Kreiter et al.
CANCER RESEARCH (2010)
Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo
A. N. Kuhn et al.
GENE THERAPY (2010)
mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers
Joanna Rejman et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Liposome-based cationic adjuvant formulations (CAF): Past, present, and future
Dennis Christensen et al.
JOURNAL OF LIPOSOME RESEARCH (2009)
Results of the first phase I/II clinical vaccination trial with direct injection of mRNA
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA
Aude Bonehill et al.
MOLECULAR THERAPY (2008)
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Katalin Kariko et al.
MOLECULAR THERAPY (2008)
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
Maria Frank-Kamenetsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Long-term storage of DNA-free RNA for use in vaccine studies
Kathryn L. Jones et al.
BIOTECHNIQUES (2007)
Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells
Ewa Grudzien-Nogalska et al.
RNA (2007)
Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent
J. Probst et al.
GENE THERAPY (2007)
Rapid optimization of gene delivery by parallel end-modification of poly(β-amino ester)s
Gregory T. Zugates et al.
MOLECULAR THERAPY (2007)
Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response
Carole Bourquin et al.
BLOOD (2007)
A plus U-rich instability elements differentially activate 5′-3′ and 3′-5′ mRNA decay
Elizabeth L. Murray et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
Silke Holtkamp et al.
BLOOD (2006)
5′-triphosphate RNA is the ligand for RIG-I
Veit Hornung et al.
SCIENCE (2006)
Toxicity of cationic lipids and cationic polymers in gene delivery
Hongtao Lv et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests
W. J. Lesterhuis et al.
ANNALS OF ONCOLOGY (2006)
Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2
J Steitz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA
K Karikó et al.
IMMUNITY (2005)
Polyethylenimine-based non-viral gene delivery systems
U Lungwitz et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA
B Scheel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Codon bias and heterologous protein expression
C Gustafsson et al.
TRENDS IN BIOTECHNOLOGY (2004)
An alphavirus replicon particle chimera derived from Venezuelan equine encephalitis and Sindbis viruses is a potent gene-based vaccine delivery vector
S Perri et al.
JOURNAL OF VIROLOGY (2003)
Novel anti-reverse cap analogs with superior translational properties
J Jemielity et al.
RNA (2003)
Share Paper
